glp-1 and cardiovascular benefits Receptor Agonists in Heart Failure Management SGLTi and GLP-1 in HF
Description
105(8): p
It shows promising results, and with its unique dosing requirements, Foundayo sets itself apart from other oral GLP-1s
Empagliflozin in heart failure with a preserved ejection fraction
Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes
[DOI] [PubMed] [Google Scholar] 618.Nikolaidis L.A., Doverspike A., Hentosz T., Zourelias L., Shen Y.T., Elahi D
In addition, cotadutide was shown to be safe and, in common with the GLP-1 analogues, was associated with dose-dependent gastrointestinal adverse events, especially nausea and vomiting [82]
